GSK shares fell after a Food and Drug Administration advisory committee voted against approval of the company's Blenrep drug, a setback for its bid to reintroduce the blood-cancer treatment in the U.S ...

Sen. Elizabeth Warren sent letters Thursday to agencies including S&P Global Ratings, Moody's Ratings and Fitch Ratings, asking for information about how they score the riskiness of private-credit ...

The jet maker said it has agreed to sell 12 of the aircraft to the airline, with options for six more. The British pharmaceutical company said combinations for its Blenrep drug were evaluated in ...

Reckitt Benckiser is selling a majority stake in its home-care business, home to Air Wick fresheners and Cillit Bang cleaning products, to Advent International in a deal that values the whole unit at ...

Actress Sarah Paulson is preparing to part ways with her longtime Los Angeles abode, putting the midcentury modern Hollywood Hills home on the market for $3 million-just weeks after admitting that she ...

The trench-coat maker on Friday booked retail revenue of 433 million pounds ($581 million) for its fiscal first quarter ended June 28. Comparable store sales dropped 1% on year. The decline was lower ...

Shares of battery-material suppliers rose in Australia too. Syrah Resources led the charge, jumping 26%. Renascor gained 18% and Talga was 10% higher. Battery-tech firm Novonix, which operates a ...

WASHINGTON-President Trump called for the release of additional documents related to the investigation of convicted sex offender Jeffrey Epstein following the publication of an article in The Wall ...

Instead of dealing with a high monthly payment on a 15-year mortgage, homeowners could make extra payments on a 30-year, ...

Netflix shares closed up 1.9% on Thursday, ahead of the release of the second-quarter results, but lost steam in the ...

--In Europe, the Stoxx Europe 600 climbed 0.3% in morning trading. France's CAC 40 increased 0.4% and Germany's DAX rose 0.3%. Vestas Wind Systems added 11.6% after an upgrade. GSK lost over 6.0%, and ...

U.S. equities have outperformed since 2008—but is it sustainable? A recent analysis reveals valuation expansion, not ...